CELCUITY INC. Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net
CELCUITY INC. (CELC) had Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net of $2.09 million as of 2026-03-31, per its 10-Q filed 2026-05-14.
Financial Statements › Notes › Debt › Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net
us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet · last filed 2026-08-13
- 2026-03-31: Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net $2.09M.
- 2025-12-31: Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net $2.62M.
- 2025-09-30: Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net $3.15M.
- 2025-06-30: Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net $1.20M.
| Period end | Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net | Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net as first filed |
|---|---|---|
| 2026-03-31 | $2.09M 10-Q · filed 2026-05-14 | |
| 2025-12-31 | $2.62M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $3.15M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $1.20M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $1.37M 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $1.61M 10-K · filed 2026-03-26 | $1.61M 10-K · filed 2025-03-31 |
| 2024-09-30 | $1.86M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $2.09M 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $419.92K 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $480.81K 10-K · filed 2025-03-31 | |
| 2023-09-30 | $540.39K 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $598.11K 10-Q · filed 2023-08-11 | |
| 2023-03-31 | $653.55K 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $707.00K 10-K · filed 2024-03-27 | |
| 2022-09-30 | $481.30K 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $319.36K 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $346.48K 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $386.58K 10-K · filed 2023-03-23 | -$386.58K 10-K · filed 2022-03-23 |
| 2021-09-30 | -$426.88K 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $466.48K 10-Q · filed 2021-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |